exicuretx.com (XCUR) - Rasio cepet

Exicure, Inc. (XCUR) focuses on developing nucleic acid therapies, relying on grants and investments due to a lack of recurring sales. Laboratories are operating according to plan, and external capacities are undergoing verification for the synthesis of new compounds. However, geopolitical tensions and the risk of supply chain disruptions from Asia complicate patent protection. This chart reflects a current market value of 0.57, demonstrating the asset's current market dynamics.

This indicator assesses the issuer's ability to settle short-term debts using its most liquid assets, completely excluding slow-moving inventories. By analyzing the quick ratio, an investor can determine the actual rate of cash reserve depletion at Exicure, Inc. (XCUR), which is critical amid the current business restructuring and aggressive cost reductions for research programs.